CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic ...

T cells are the immune system’s frontline fighters. When they detect danger, they rapidly multiply and transform into ...

Immunotherapy is gaining traction as a prominent approach to cancer treatment. These therapies encompass the use of Chimeric ...

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable ...

Secura Bio, Inc. ( ), an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

Adding IL-12 to mRNA vaccines can lead to longer lasting protective effect and a potential approach for reducing the risk of ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...